Literature DB >> 29377070

Factors influencing risk-based care of the childhood cancer survivor in the 21st century.

Stephanie B Dixon1, Kari L Bjornard1, Nicole M Alberts2, Gregory T Armstrong3, Tara M Brinkman4, Wassim Chemaitilly5, Matthew J Ehrhardt6, Israel Fernandez-Pineda7, Lisa M Force1, Todd M Gibson8, Daniel M Green9, Carrie R Howell10, Sue C Kaste11, Anne C Kirchhoff12, James L Klosky13, Kevin R Krull14, John T Lucas15, Daniel A Mulrooney16, Kirsten K Ness3, Carmen L Wilson8, Yutaka Yasui3, Leslie L Robison3, Melissa M Hudson9.   

Abstract

The population of adult survivors of childhood cancer continues to grow as survival rates improve. Although it is well established that these survivors experience various complications and comorbidities related to their malignancy and treatment, this risk is modified by many factors that are not directly linked to their cancer history. Research evaluating the influence of patient-specific demographic and genetic factors, premorbid and comorbid conditions, health behaviors, and aging has identified additional risk factors that influence cancer treatment-related toxicity and possible targets for intervention in this population. Furthermore, although current long-term follow-up guidelines comprehensively address specific therapy-related risks and provide screening recommendations, the risk profile of the population continues to evolve with ongoing modification of treatment strategies and the emergence of novel therapeutics. To address the multifactorial modifiers of cancer treatment-related health risk and evolving treatment approaches, a patient-centered and risk-adapted approach to care that often requires a multidisciplinary team approach, including medical and behavioral providers, is necessary for this population. CA Cancer J Clin 2018;68:133-152.
© 2018 American Cancer Society. © 2018 American Cancer Society.

Entities:  

Keywords:  adolescent; antineoplastic agents; cancer; child; delivery of health care; neoplasms; risk; survivors; treatment outcome

Mesh:

Year:  2018        PMID: 29377070      PMCID: PMC8893118          DOI: 10.3322/caac.21445

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  194 in total

Review 1.  Reproductive physiology and treatment-related loss of sex hormone production.

Authors:  C Sklar
Journal:  Med Pediatr Oncol       Date:  1999-07

2.  Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy.

Authors:  Rodrigo B Interiano; Noel Delos Santos; Sujuan Huang; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Daniel M Green; Andrew M Davidoff
Journal:  Cancer       Date:  2015-04-01       Impact factor: 6.860

Review 3.  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Saro H Armenian; Melissa M Hudson; Renee L Mulder; Ming Hui Chen; Louis S Constine; Mary Dwyer; Paul C Nathan; Wim J E Tissing; Sadhna Shankar; Elske Sieswerda; Rod Skinner; Julia Steinberger; Elvira C van Dalen; Helena van der Pal; W Hamish Wallace; Gill Levitt; Leontien C M Kremer
Journal:  Lancet Oncol       Date:  2015-03       Impact factor: 41.316

4.  Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study.

Authors:  Gregory T Armstrong; Toana Kawashima; Wendy Leisenring; Kayla Stratton; Marilyn Stovall; Melissa M Hudson; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2014-03-17       Impact factor: 44.544

5.  Efficacy of a tobacco quitline among adult survivors of childhood cancer.

Authors:  Robert C Klesges; Rebecca A Krukowski; James L Klosky; Wei Liu; Deo Kumar Srivastava; James M Boyett; Jennifer Q Lanctot; Melissa M Hudson; Charla Folsom; Leslie L Robison
Journal:  Nicotine Tob Res       Date:  2014-10-21       Impact factor: 4.244

6.  Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging.

Authors:  Hany Ariffin; Mohamad Shafiq Azanan; Sayyidatul Syahirah Abd Ghafar; Lixian Oh; Kee Hie Lau; Tharshanadhevasheri Thirunavakarasu; Atiqah Sedan; Kamariah Ibrahim; Adelyne Chan; Tong Foh Chin; Fong Fong Liew; Shareni Jeyamogan; Erda Syerena Rosli; Rashidah Baharudin; Tsiao Yi Yap; Roderick Skinner; Su Han Lum; Pierre Hainaut
Journal:  Cancer       Date:  2017-06-27       Impact factor: 6.860

7.  Effectiveness of an integrated adventure-based training and health education program in promoting regular physical activity among childhood cancer survivors.

Authors:  H C William Li; Oi Kwan Joyce Chung; Ka Yan Ho; Sau Ying Chiu; Violeta Lopez
Journal:  Psychooncology       Date:  2013-06-04       Impact factor: 3.894

8.  Clinical ascertainment of health outcomes among adults treated for childhood cancer.

Authors:  Melissa M Hudson; Kirsten K Ness; James G Gurney; Daniel A Mulrooney; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Gregory T Armstrong; Kerri A Nottage; Kendra E Jones; Charles A Sklar; Deo Kumar Srivastava; Leslie L Robison
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

9.  Health insurance coverage, care accessibility and affordability for adult survivors of childhood cancer: a cross-sectional study of a nationally representative database.

Authors:  Karen A Kuhlthau; Ryan D Nipp; Amy Shui; Sean Srichankij; Anne C Kirchhoff; Alison A Galbraith; Elyse R Park
Journal:  J Cancer Surviv       Date:  2016-04-12       Impact factor: 4.442

10.  Long-term inpatient disease burden in the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors.

Authors:  Sofie de Fine Licht; Kathrine Rugbjerg; Thorgerdur Gudmundsdottir; Trine G Bonnesen; Peter Haubjerg Asdahl; Anna Sällfors Holmqvist; Laura Madanat-Harjuoja; Laufey Tryggvadottir; Finn Wesenberg; Henrik Hasle; Jeanette F Winther; Jørgen H Olsen
Journal:  PLoS Med       Date:  2017-05-09       Impact factor: 11.069

View more
  14 in total

1.  Dissociation of Pubertal Development Abnormality and Gonadal Dysfunction in Childhood Cancer Survivors.

Authors:  Bo Yu; Rani Fritz; Mario Vega; Margret Merino
Journal:  J Adolesc Young Adult Oncol       Date:  2020-03-18       Impact factor: 2.223

Review 2.  The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress.

Authors:  Stephanie B Dixon; Eric J Chow; Lars Hjorth; Melissa M Hudson; Leontien C M Kremer; Lindsay M Morton; Paul C Nathan; Kirsten K Ness; Kevin C Oeffinger; Gregory T Armstrong
Journal:  Pediatr Clin North Am       Date:  2020-12       Impact factor: 3.278

3.  Hispanic Orientation and Cancer-Related Knowledge in Childhood Cancer Survivors.

Authors:  Alix G Sleight; Cynthia N Ramirez; Kimberly A Miller; Joel E Milam
Journal:  J Adolesc Young Adult Oncol       Date:  2018-12-13       Impact factor: 2.223

4.  Applications of Artificial Intelligence in Pediatric Oncology: A Systematic Review.

Authors:  Siddhi Ramesh; Sukarn Chokkara; Timothy Shen; Ajay Major; Samuel L Volchenboum; Anoop Mayampurath; Mark A Applebaum
Journal:  JCO Clin Cancer Inform       Date:  2021-12

5.  Multimorbidity patterns and risk of hospitalisation in children: A population cohort study of 3.6 million children in England, with illustrative examples from childhood cancer survivors.

Authors:  Sheng-Chia Chung; Stefanie Mueller; Katherine Green; Wai Hoong Chang; Darren Hargrave; Alvina G Lai
Journal:  Lancet Reg Health Eur       Date:  2022-06-30

6.  Long-term Follow-up Care for Childhood, Adolescent, and Young Adult Cancer Survivors.

Authors:  Melissa M Hudson; Smita Bhatia; Jacqueline Casillas; Wendy Landier
Journal:  Pediatrics       Date:  2021-09       Impact factor: 9.703

7.  Pre- and Posttherapy Risk Factors for Vasculopathy in Pediatric Patients With Craniopharyngioma Treated With Surgery and Proton Radiation Therapy.

Authors:  John T Lucas; Austin M Faught; Chih Yang Hsu; Lydia J Wilson; Yian Guo; Yimei Li; Raja Khan; Jared B Becksfort; David A LeVine; Yousef Ismael; Kaleb Darrow; Vadim P Moskvin; Fakhriddin Pirlepesov; Paul Klimo; Lucas Elijovich; Daniel J Indelicato; Fredrick A Boop; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2022-01-03       Impact factor: 8.013

8.  p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

Authors:  Alessandro Carugo; Rosalba Minelli; Luigi Sapio; Melinda Soeung; Federica Carbone; Frederick S Robinson; James Tepper; Ziheng Chen; Sara Lovisa; Maria Svelto; Samirkumar Amin; Sanjana Srinivasan; Edoardo Del Poggetto; Sara Loponte; Francesca Puca; Prasenjit Dey; Gabriel G Malouf; Xiaoping Su; Liren Li; Dolores Lopez-Terrada; Dinesh Rakheja; Alexander J Lazar; George J Netto; Priya Rao; Alessandro Sgambato; Anirban Maitra; Durga N Tripathi; Cheryl L Walker; Jose A Karam; Timothy P Heffernan; Andrea Viale; Charles W M Roberts; Pavlos Msaouel; Nizar M Tannir; Giulio F Draetta; Giannicola Genovese
Journal:  Cancer Cell       Date:  2019-02-11       Impact factor: 38.585

Review 9.  Physical activity interventions in pediatric, adolescent, and young adult cancer survivors: a systematic review.

Authors:  Sylvia L Crowder; Acadia W Buro; Marilyn Stern
Journal:  Support Care Cancer       Date:  2022-01-22       Impact factor: 3.359

10.  Patterns and trends of cancer incidence in children and adolescents in China, 2011-2015: A population-based cancer registry study.

Authors:  Kexin Sun; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Shaoming Wang; Ru Chen; Wenqiang Wei; Jie He
Journal:  Cancer Med       Date:  2021-06-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.